Yesq Tablet is a pharmaceutical formulation combining Coenzyme Q10 (100 mg) and Levo-carnitine (500 mg), designed to support cellular energy metabolism and enhance mitochondrial function. Coenzyme Q10, a lipid-soluble antioxidant, plays a critical role in the electron transport chain, facilitating adenosine triphosphate (ATP) production and reducing oxidative stress within cells. Levo-carnitine, a naturally occurring amino acid derivative, is essential for the transport of long-chain fatty acids into mitochondria, promoting fatty acid oxidation and energy generation. The synergistic action of these active ingredients makes Yesq Tablet beneficial in managing conditions associated with mitochondrial dysfunction, fatigue, and impaired energy metabolism, such as chronic heart failure, cardiomyopathy, and certain neuromuscular disorders. Additionally, it may support recovery in patients undergoing statin therapy or those with age-related decline in endogenous Coenzyme Q10 levels. Yesq Tablet is generally well-tolerated; however, it should be used under medical supervision, especially in patients with underlying metabolic or cardiovascular conditions. Contraindications include hypersensitivity to any component of the formulation. Dosage and duration of therapy should be individualized based on clinical response and physician assessment. This combination therapy offers a targeted approach to enhancing cellular bioenergetics and improving overall functional capacity.